Mark T. Gladwin, MD

Mark T. Gladwin, MDMark T. Gladwin, MD
Vice President for Medical Affairs and Dean of the School of Medicine

A physician-scientist, clinician, educator, and academic leader, Mark Gladwin began his tenure as dean of the University of Maryland School of Medicine (UMSOM) in August 2022. He also is the John Z. and Akiko K. Bowers Distinguished Professor at UMSOM and vice president for medical affairs for the University of Maryland, Baltimore (UMB).

Gladwin joined UMSOM after serving as the Jack D. Myers Professor and chair of the Department of Medicine, associate dean for physician-scientist mentoring, and associate vice chancellor for science strategy, health sciences, at the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center.

In the latter two roles, Gladwin led the strategic direction of health sciences research efforts at the school and medical center, with an additional focus on career development programs for the next generation of physicians and scientists in translational research.

Gladwin was recruited to the University of Pittsburgh in 2008 to serve as chief of the Division of Pulmonary, Allergy and Critical Care Medicine and the inaugural director of the Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute. He has a long history of leading translational projects and programs and has trained students at all levels, from undergraduate students to junior faculty, many of whom have established intendent careers in academic medicine.

Gladwin received his medical degree from the University of Miami Honors Program in Medical Education in 1991. After completing his internship and chief residency in internal medicine at Oregon Health Sciences University in Portland, he joined the National Institutes of Health (NIH) in 1995 as a critical care fellow. After completing a clinical fellowship in pulmonary medicine at the University of Washington in Seattle, Gladwin served as chief of the Pulmonary and Vascular Medicine Branch within the National Heart, Lung, and Blood Institute, an arm of NIH.

An expert in pulmonary hypertension and sickle cell disease, Gladwin has served as a principal or associate investigator on more than 25 clinical trials. Since 1998, his research activities have led to more than 200 published, peer-reviewed manuscripts, and he is the co-author of the textbooks “Clinical Microbiology Made Ridiculously Simple” and “Critical Care and Hospitalist Medicine Made Ridiculously Simple.”

Gladwin is a member of Alpha Omega Alpha, the American Society for Clinical Investigation (ASCI), the Association of Professors of Medicine (APM), and the Association of American Physicians, and he has served on the ASCI and APM councils. He is a fellow of the American College of Physicians, American Heart Association (AHA), Association of American Physicians (AAP), and Pulmonary Vascular Research Institute.

He has received numerous academic awards including the U.S. Public Health Service Achievement Award, the NIH Director’s Award for Mentoring, the NIH Clinical Center Director’s Award for Science, the NIH Merit Award in recognition for accomplishments in both basic and clinical sciences, and the Recognition Award for Scientific Accomplishments from the American Thoracic Society. Gladwin also was named an AHA Distinguished Scientist and was recognized as a Distinguished Professor by the University of Pittsburgh in 2014.